Bioceres reported 1Q26 results with continued revenue declines but improved gross margins and significant OpEx reductions, boosting profitability. BIOX faces severe financial risks, including default ...
Capehart and Wehner on Trump’s reaction to the National Guard shooting Jonathan Capehart of MS NOW and Peter Wehner, a contributing writer at The Atlantic and a senior fellow at the Trinity Forum, ...